HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pier Luigi Zinzani Selected Research

Antibodies

1/2023Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
9/2020Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study.
1/2019The role of transplantation in Hodgkin lymphoma.
8/2004Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pier Luigi Zinzani Research Topics

Disease

85Lymphoma (Lymphomas)
12/2023 - 05/2002
62Hodgkin Disease (Hodgkin's Disease)
03/2024 - 08/2002
49Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2023 - 08/2002
46Neoplasms (Cancer)
04/2024 - 02/2002
44Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 03/2005
40B-Cell Lymphoma (Lymphoma, B Cell)
03/2024 - 12/2002
33Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2024 - 11/2003
23Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2024 - 05/2005
21Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2024 - 07/2012
18Disease Progression
01/2023 - 08/2011
17B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2024 - 01/2004
15Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
03/2024 - 09/2005
15Neutropenia
12/2023 - 01/2004
11Hairy Cell Leukemia
04/2024 - 03/2004
10Thrombocytopenia (Thrombopenia)
12/2023 - 12/2006
9Mycosis Fungoides
01/2022 - 09/2005
8T-Cell Lymphoma (Lymphoma, T Cell)
01/2020 - 05/2005
7Hematologic Neoplasms (Hematological Malignancy)
03/2023 - 11/2016
7Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2022 - 01/2012
7Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
10/2019 - 05/2002
6Peripheral Nervous System Diseases (PNS Diseases)
12/2021 - 08/2011
6Cardiotoxicity
01/2021 - 07/2012
6Anemia
10/2019 - 01/2004
5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2024 - 07/2014
5Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2023 - 10/2018
4Cytokine Release Syndrome
03/2023 - 12/2020
4COVID-19
01/2023 - 01/2021
4Diarrhea
12/2021 - 10/2012
4Nausea
11/2021 - 09/2006
4Hypertension (High Blood Pressure)
11/2021 - 10/2020
4Pneumonia (Pneumonitis)
01/2021 - 08/2011
4Hemorrhage
12/2020 - 09/2006
3Infections
05/2024 - 08/2011
3Exanthema (Rash)
12/2023 - 11/2020

Drug/Important Bio-Agent (IBA)

51Rituximab (Mabthera)FDA Link
02/2024 - 09/2003
41Brentuximab VedotinIBA
03/2024 - 08/2013
22Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 02/2005
20Lenalidomide (CC 5013)FDA Link
11/2023 - 08/2011
19Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 05/2004
17pembrolizumabIBA
01/2024 - 11/2016
15ibrutinibIBA
05/2024 - 03/2017
15Vincristine (Oncovin)FDA LinkGeneric
10/2022 - 05/2004
15fludarabineIBA
06/2016 - 01/2004
14Prednisone (Sone)FDA LinkGeneric
10/2022 - 05/2004
13Bendamustine HydrochlorideFDA Link
12/2023 - 07/2012
12Agammaglobulinaemia Tyrosine KinaseIBA
02/2024 - 01/2018
12Monoclonal AntibodiesIBA
05/2023 - 03/2014
12Mitoxantrone (Novantrone)FDA LinkGeneric
06/2016 - 07/2004
11AnthracyclinesIBA
01/2022 - 11/2003
9Bleomycin (Blenoxane)FDA LinkGeneric
11/2021 - 06/2008
8CladribineFDA LinkGeneric
04/2024 - 03/2004
8Chimeric Antigen ReceptorsIBA
12/2023 - 01/2021
8pixantrone (BBR 2778)IBA
12/2023 - 09/2006
8Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2023 - 10/2006
8idelalisibIBA
01/2022 - 03/2014
8Dacarbazine (DIC)FDA LinkGeneric
11/2021 - 06/2008
8Vinblastine (Vinblastine Sulfate)FDA Link
11/2021 - 06/2008
8ibritumomab tiuxetan (Zevalin)FDA Link
11/2019 - 07/2007
8Bortezomib (Velcade)FDA Link
01/2018 - 09/2007
7NivolumabIBA
03/2024 - 09/2016
7copanlisibIBA
11/2023 - 03/2017
7Etoposide (VP 16)FDA LinkGeneric
08/2017 - 08/2002
6zanubrutinibIBA
03/2024 - 12/2020
6Methotrexate (Mexate)FDA LinkGeneric
09/2023 - 10/2009
6mogamulizumabIBA
01/2022 - 03/2016
6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2003
5obinutuzumabIBA
12/2023 - 10/2015
5Biomarkers (Surrogate Marker)IBA
10/2023 - 05/2013
5tafasitamabIBA
09/2023 - 11/2021
5LigandsIBA
12/2021 - 09/2016
5Phosphotransferases (Kinase)IBA
11/2021 - 03/2015
5GemcitabineFDA Link
08/2017 - 12/2005
510-propargyl-10-deazaaminopterinFDA Link
07/2017 - 07/2010
5romidepsin (FK228)FDA Link
01/2017 - 03/2016
5Yttrium-90IBA
08/2010 - 07/2007
4polatuzumab vedotinIBA
09/2023 - 05/2019
4loncastuximab tesirineIBA
08/2023 - 01/2021
4acalabrutinibIBA
07/2023 - 01/2018
4AntibodiesIBA
01/2023 - 08/2004
4Biosimilar PharmaceuticalsIBA
08/2022 - 12/2017
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
4liposomal doxorubicin (Doxil)FDA Link
10/2020 - 01/2015
4Alkylating AgentsIBA
01/2017 - 01/2003
4IfosfamideFDA LinkGeneric
04/2016 - 08/2002
3Phosphatidylinositols (Phosphatidylinositol)IBA
04/2024 - 11/2021
3tisagenlecleucelIBA
01/2024 - 01/2022
3parsaclisibIBA
12/2023 - 08/2023

Therapy/Procedure

94Therapeutics
04/2024 - 02/2002
48Drug Therapy (Chemotherapy)
03/2024 - 08/2002
31Stem Cell Transplantation
05/2024 - 04/2003
11Salvage Therapy
12/2023 - 02/2004
11Radiotherapy
11/2021 - 12/2002
11Radioimmunotherapy
05/2020 - 02/2008
8Autologous Transplantation
02/2024 - 05/2003
6Homologous Transplantation
01/2024 - 08/2012
6Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2015 - 01/2005
5Immunotherapy
12/2021 - 02/2008
4Aftercare (After-Treatment)
04/2024 - 03/2004
4Transplantation
01/2024 - 07/2017
4Combination Drug Therapy (Combination Chemotherapy)
09/2023 - 11/2003